Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Bierer

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Neurobiology of Aging|January 1, 1991
Platelet phospholipid synthesis in Alzheimer's diseaseP D Kanof, R C Mohs, J Gross, et al.
Neuroscience Letters|May 28, 1993
Widespread deficits in somatostatin but not neuropeptide Y concentrations in Alzheimer's disease cerebral cortexS M Gabriel, L M Bierer, V Harotunian, et al.
Biological Psychiatry|June 15, 1995
Lack of association between clinical symptoms and postmortem indices of brain serotonin function in Alzheimer's diseaseB A Lawlor, T M Ryan, L M Bierer, et al.
Archives of Neurology|September 1, 1992
Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia. Regional and laminar distribution of neurofibrillary tangles and senile plaquesP R Hof, L M Bierer, D P Perl, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1991
Cholinergic strategies in the treatment of Alzheimer's diseaseM Davidson, R G Stern, L M Bierer, et al.
Archives of Neurology|January 1, 1995
Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's diseaseL M Bierer, P R Hof, D P Purohit, et al.
Psychiatry Research|May 1, 1992
Deterioration on the Blessed test in Alzheimer's disease: longitudinal data and their implications for clinical trials and identification of subtypesR G Stern, R C Mohs, L M Bierer, et al.
Alzheimer Disease and Associated Disorders|January 1, 1993
A pilot study of oral physostigmine plus yohimbine in patients with Alzheimer diseaseL M Bierer, P S Aisen, M Davidson, et al.
Biological Psychiatry|January 15, 1996
Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortexS M Gabriel, M Davidson, V Haroutunian, et al.
Psychiatry Research|October 16, 1995
L-deprenyl and physostigmine for the treatment of Alzheimer's diseaseD B Marin, L M Bierer, B A Lawlor, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Neurobiology of Aging|January 1, 1991
Platelet phospholipid synthesis in Alzheimer's diseaseP D Kanof, R C Mohs, J Gross, et al.
Neuroscience Letters|May 28, 1993
Widespread deficits in somatostatin but not neuropeptide Y concentrations in Alzheimer's disease cerebral cortexS M Gabriel, L M Bierer, V Harotunian, et al.
Biological Psychiatry|June 15, 1995
Lack of association between clinical symptoms and postmortem indices of brain serotonin function in Alzheimer's diseaseB A Lawlor, T M Ryan, L M Bierer, et al.
Archives of Neurology|September 1, 1992
Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia. Regional and laminar distribution of neurofibrillary tangles and senile plaquesP R Hof, L M Bierer, D P Perl, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1991
Cholinergic strategies in the treatment of Alzheimer's diseaseM Davidson, R G Stern, L M Bierer, et al.
Archives of Neurology|January 1, 1995
Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's diseaseL M Bierer, P R Hof, D P Purohit, et al.
Psychiatry Research|May 1, 1992
Deterioration on the Blessed test in Alzheimer's disease: longitudinal data and their implications for clinical trials and identification of subtypesR G Stern, R C Mohs, L M Bierer, et al.
Alzheimer Disease and Associated Disorders|January 1, 1993
A pilot study of oral physostigmine plus yohimbine in patients with Alzheimer diseaseL M Bierer, P S Aisen, M Davidson, et al.
Biological Psychiatry|January 15, 1996
Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortexS M Gabriel, M Davidson, V Haroutunian, et al.
Psychiatry Research|October 16, 1995
L-deprenyl and physostigmine for the treatment of Alzheimer's diseaseD B Marin, L M Bierer, B A Lawlor, et al.
Pageof 3